TAMSULOSIN HCL IP 0.4 MG Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
TAMSULOSIN HCL IP 0.4 MG Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Selective alpha-1A adrenergic blocker
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our TAMSULOSIN HCL IP 0.4 MG Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following TAMSULOSIN HCL IP 0.4 MG Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
TAMSULOSIN HCL IP 0.4 MG Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our TAMSULOSIN HCL IP 0.4 MG formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Benign prostatic hyperplasia (BPH) LUTS
- Medical expulsive therapy for lower ureteric stones
- Female LUTS (off-label)
- Post-prostatectomy LUTS
Mechanism of Action
Tamsulosin selectively blocks alpha-1A adrenergic receptors predominantly expressed in the prostate, bladder neck and distal ureter — relaxing smooth muscle and improving urine flow. The selectivity gives less effect on vascular alpha-1B receptors, reducing orthostatic hypotension risk.
Dosage & Administration
- Adults: 1 tablet (0.4 mg) once daily, 30 minutes after the same meal each day
- Swallow whole
- Continue long-term for BPH
Side Effects
- Postural hypotension and dizziness
- Ejaculatory dysfunction
- Headache
- Rhinitis
- Floppy iris syndrome (during cataract surgery)
Contraindications
- History of orthostatic hypotension
- Severe hepatic impairment
- Concurrent strong CYP3A4 inhibitors
- Hypersensitivity to tamsulosin
Storage
Store below 25°C.
PCD Pharma Franchise for TAMSULOSIN HCL IP 0.4 MG Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for TAMSULOSIN HCL IP 0.4 MG Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of TAMSULOSIN HCL IP 0.4 MG Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of TAMSULOSIN HCL IP 0.4 MG Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of TAMSULOSIN HCL IP 0.4 MG Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is TAMSULOSIN HCL IP 0.4 MG Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer TAMSULOSIN HCL IP 0.4 MG Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for TAMSULOSIN HCL IP 0.4 MG Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for TAMSULOSIN HCL IP 0.4 MG Tablet?
MRPs range from ₹995 to ₹995 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for TAMSULOSIN HCL IP 0.4 MG Tablet?